Weight loss medications are gaining traction, and it’s estimated that the global market for these therapies could hit $150 billion by 2035. Drugs like GLP-1 agonists—semaglutide-based options such as Ozempic, Wegovy, Mounjaro, and Zepbound—are primarily designed to treat type 2 diabetes and manage obesity.
Interestingly, recent research suggests additional benefits that doctors are beginning to recommend, including a lower risk of heart disease and dementia. Despite this, a recent study from Yale found that only about 3% of adults eligible for such treatments actually receive a prescription.
Should You Consider Weight Loss Medications?
According to Dr. John Anderson, an internist and diabetes expert in Nashville, most adults struggling with obesity are suitable candidates for these medications. He emphasizes that the most crucial group to assist includes those facing obesity alongside other serious health issues like type 2 diabetes or hypertension.
“Anyone who wishes to lose weight while being obese is a likely candidate,” he noted. “But, from a healthcare viewpoint, my priority is definitely the high-risk patients.”
To be eligible for weight-loss medications, individuals must initially collaborate with their healthcare providers on lifestyle adjustments, which include diet, exercise, sleep, and stress management. Dr. Michael Aziz, a physician based in New York City, states that starting with a balanced diet rich in vegetables and low-sugar fruits is vital for weight loss.
“That said, some people struggle to shed pounds despite their best efforts, often due to injuries or a slower metabolism,” he added. This underscores the importance of addressing obesity early, as it can help prevent further complications, he argued.
Insurance typically covers these weight-loss medications for individuals with a body mass index (BMI) over 27. As per the National Institutes of Health, a BMI of 25-29.9 classifies someone as obese, while a BMI above 30 indicates more severe obesity.
Beyond helping high-risk individuals, Anderson expressed the hope that these drugs could become both accessible and affordable for a broader range of patients dealing with obesity.
“Treating obesity early can halt disease progression,” he pointed out, noting that GLP-1 medications can lower the chance of developing type 2 diabetes by 94% while significantly mitigating major cardiovascular risks. Obesity is linked to over 200 health issues, including heart and kidney diseases, not to mention around 40% of all cancers—which stresses the necessity of early intervention.
The Benefits Extending Beyond Obesity and Diabetes
According to Anderson, numerous studies are currently exploring the use of weight-loss medications for addressing various conditions, including alcoholism, dementia, and liver disease. “These drugs work by emptying the stomach while also influencing appetite regulation in the brain, effectively silencing food cravings,” he noted.
Although more research is needed, Anderson mentioned that preliminary findings suggest these medications might significantly help those struggling with addiction.
Aziz highlights that GLP-1 drugs can reduce heart attack and stroke risks by about 20% and may assist in reversing fatty liver disease and improving sleep apnea as well.
Potential Risks and Limitations
It’s well-documented that diabetes and obesity medications can lead to gastrointestinal side effects, including nausea and diarrhea, particularly at higher doses. Anderson reassures patients that while these effects may be bothersome initially, they usually diminish over time. However, doctors recommend that those with a family history of thyroid cancer or pancreatitis should steer clear of these medications. Pregnant individuals are also advised against them.
Moreover, some patients report experiencing side effects like muscle loss, hair thinning, mood changes, and other unwanted symptoms. “It’s crucial for individuals to recognize that GLP-1 medications aren’t a miracle fix for weight loss; they need to be paired with healthy lifestyle choices,” says Beltre, emphasizing that such medications are only one piece of a larger puzzle.
Finally, physicians do stress that these treatments shouldn’t be seen as a long-term solution, but many report that the benefits often outweigh the potential risks. Many patients have experienced considerable weight loss and can engage in activities they hadn’t been able to for years, such as ice skating or walking without pain, which speaks volumes about the value of these therapies.
For those considering weight loss medications, consulting a healthcare provider is essential to weigh both the possible benefits and risks involved.
